Amanda Golembesky

1. HOCHMAIR, Maximilian J, MORABITO, Alessandro, HAO, Desiree, YANG, Cheng-Ta, SOO, Ross A, YANG, James C-H, GUCALP, Rasim, HALMOS, Balazs, WANG, Lara, GOLEMBESKY, Amanda, MÄRTEN, Angela, ČUFER, Tanja. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer : an observational study. Future oncology. Nov. 2018, vol. 14, no. 27, str. 2861-2874, ilustr. ISSN 1744-8301. https://www.futuremedicine.com/doi/full/10.2217/fon-2018-0711?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed#, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.2217/fon-2018-0711. [COBISS.SI-ID 2048432753]

2. HOCHMAIR, Maximilian J, MORABITO, Alessandro, HAO, Desiree, YANG, Cheng-Ta, SOO, Ross A, YANG, James C-H, GUCALP, Rasim, HALMOS, Balazs, WANG, Lisa, GOLEMBESKY, Amanda, MÄRTEN, Angela, ČUFER, Tanja. Afatinib followed by osimertinib in patients with EGFR mutationpositive (EGFRm1) advanced NSCLC : updated data from the GioTag real-world study. Annals of oncology. Supplement : an official Journal of the European Society for Medical Oncology and the official journal of the Japanese Society of Medical Oncology. Oct. 2019, vol. 30, suppl. 5, str. v629. ISSN 1572-610X. https://www.sciencedirect.com/science/article/pii/S0923753419597393. [COBISS.SI-ID 16144387]